June 2024
M	T	W	T	F	S	S
	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Blog

Paolo Tarantino: I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections

Photo of Paolo Tarantino and Giuseppe Curigliano

May 25, 2024, 15:15

Paolo Tarantino: I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections

Paolo Tarantino shared on LinkedIn:

“I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections!

A compassionate clinician and true leader in drug development, Giuseppe has tirelessly inspired me and an entire generation of young physicians, with a transformative impact on worldwide oncology.

His dedication to the growth of ESMO, of its open access journal ESMO Open, of the Guidelines, Preceptorships, the ESMO Breast Congress and dozens of terrific ESMO activities can’t be overstated.

Under his lead, the society would certainly further flourish and expand its horizons, at the benefit of patients, physicians, researchers and all stakeholders involved in the fight of cancer.

Make sure to vote for him between May 28 and June 10!”

No alternative text description for this image

Source: Paolo Tarantino/LinkedIn

Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and research.